7 years ago
Mylan chairman: Drug pricing critics ought to go copulate with themselves
Some pharmaceutical companies are troubled by stratospheric drug prices. Several have vowed to limit price hikes, for instance. And the powerful drug lobbying group PhRMA is at least trying to distract consumers’ attention away from price gouging by dangling shiny advertisements about their life-saving research. But there are some companies that just don’t care. Mylan appears to be one of those.
Continue Reading
https://arstechnica.com
Join the Discussion